Is a Testosterone of 1,200 Really Supraphysiologic? What Healthy Young Men Actually Produce
A man on testosterone replacement therapy gets his labs back:
Total testosterone: 1,200 ng/dL.
Someone looks at the laboratory reference range and immediately says:
“That’s supraphysiologic.”
Maybe.
But that word is doing more work than most people realize.
A testosterone level of 1,200 ng/dL is above the modern CDC-harmonized reference interval, but it is not biologically impossible in a healthy untreated man and should not be interpreted without considering assay method, SHBG, free testosterone, and timing.
A testosterone level of 1,200 ng/dL is clearly above the upper limit of many modern laboratory reference ranges. The widely cited CDC-harmonized reference interval for healthy, nonobese men ages 19–39 places the 97.5th percentile at approximately 916 ng/dL.
Yet an earlier Framingham Heart Study analysis of healthy young men—using LC-MS/MS—reported a 97.5th percentile of approximately 1,197 ng/dL and a 99th percentile of 1,322 ng/dL.
So what happened?
Did healthy men once produce testosterone levels around 1,200 ng/dL, only for those levels to somehow become “abnormal” several years later?
Was the older assay inaccurate?
Have testosterone levels declined across generations?
Or are we confusing three different concepts:
physiology, population reference ranges, and treatment targets?
The answer requires a little more nuance than drawing a red line at 916.
Let’s take a look.
What Did Healthy Young Men Actually Measure in Framingham?
In 2011, Bhasin and colleagues published testosterone reference ranges from the Framingham Heart Study Generation 3 cohort.
The reference group included 456 healthy, nonobese men ages 19–40.
Importantly, their total testosterone was not measured using an old nonspecific radioimmunoassay.
It was measured by liquid chromatography–tandem mass spectrometry, or LC-MS/MS.
The resulting testosterone distribution looked like this:
| Percentile | Total Testosterone |
|---|---|
| 1st | 282 ng/dL |
| 2.5th | 348 ng/dL |
| 5th | 406 ng/dL |
| Median | 699 ng/dL |
| 95th | 1,124 ng/dL |
| 97.5th | 1,196.6 ng/dL |
| 99th | 1,322 ng/dL |
The mean testosterone concentration was approximately 724 ng/dL.
That is worth appreciating.
In this carefully selected healthy-young-male reference population, approximately 2.5% of men measured above about 1,197 ng/dL using that laboratory method.
And approximately 1% were above 1,322 ng/dL.
Those men were not being treated with testosterone.
So a measured testosterone concentration around 1,200 ng/dL is clearly biologically possible in an untreated healthy man.
But that still does not answer whether 1,200 should be considered a normal therapeutic target.
And there is another wrinkle.
Why Does the Modern Reference Range Stop Around 916?
Several years later, investigators published what became one of the most influential testosterone reference-range studies.
They pooled data from four major cohorts comprising more than 9,000 men:
Framingham Heart Study
European Male Aging Study
Osteoporotic Fractures in Men Study
Male Sibling Study of Osteoporosis
The problem they were trying to solve was straightforward:
Different laboratories were producing different testosterone values.
Even when laboratories use sophisticated assays such as LC-MS/MS, they may use different:
calibrators
extraction techniques
internal standards
chromatography methods
instruments
calibration curves
That can create systematic differences between laboratories.
In other words:
LC-MS/MS describes the technology. It does not guarantee that every LC-MS/MS assay in every laboratory will report an identical number from the same sample.
What Does “CDC Harmonization” Actually Mean?
The investigators took approximately 100 stored samples from each cohort and measured them using a testosterone reference method at the CDC.
They then compared those CDC results with the values originally produced by each cohort’s laboratory.
From that comparison, they developed mathematical conversion equations that allowed the larger datasets to be placed onto a common CDC-calibrated scale.
Think of it like having several high-quality bathroom scales.
One consistently reads:
200 lb
while another consistently reads:
194 lb
for the same person.
Both scales may be extremely precise.
But if we want to compare thousands of people measured on different scales, we first need to determine how each scale relates to a common reference.
That is what testosterone harmonization attempted to accomplish.
It was not simply:
“Old inaccurate test → new accurate test.”
The original Framingham testosterone measurements were already performed using LC-MS/MS.
This was primarily about getting different sophisticated assays onto the same measurement scale.
And the Numbers Changed Dramatically
After harmonization, healthy nonobese men ages 19–39 had the following pooled testosterone distribution:
| Percentile | CDC-Harmonized Total Testosterone |
|---|---|
| 2.5th | 264 ng/dL |
| 5th | 303 ng/dL |
| 10th | 349 ng/dL |
| 25th | 428 ng/dL |
| Median | 531 ng/dL |
| 75th | 645 ng/dL |
| 90th | 773 ng/dL |
| 95th | 852 ng/dL |
| 97.5th | 916 ng/dL |
That is the source of the frequently cited 264–916 ng/dL reference interval.
At first glance, that appears completely inconsistent with the earlier Framingham data.
But this is the key:
The original Framingham distribution itself changed when placed onto the CDC scale.
The original Framingham 97.5th percentile was approximately:
1,197 ng/dL
After cross-calibration to the CDC reference system, the corresponding upper range from Framingham was approximately:
923 ng/dL
The pooled harmonized upper limit was:
916 ng/dL.
The men had not suddenly changed.
The numerical scale used to express their testosterone values had.
That is one of the most important lessons in this entire discussion:
A testosterone result represents biology measured through an analytical system.
The number and the assay cannot be completely separated.
So Was 1,197 “Wrong”?
Not exactly.
This is where the language matters.
The original Framingham value was produced by a legitimate LC-MS/MS assay and described what that assay measured in that reference population.
The later harmonization study did not discover that those men secretly had testosterone levels hundreds of points lower.
Instead, researchers asked a different question:
What would testosterone measurements from these different studies look like if they were all expressed relative to the same CDC reference method?
Harmonization made the different cohorts much more comparable.
That is extremely important when creating universal reference ranges.
But it also teaches us why saying something like:
“916 is the highest physiologic testosterone a healthy man can produce”
would be incorrect.
916 is a statistical upper reference limit on a particular harmonized measurement scale.
It is not a biological wall.
Reference Range Does Not Mean Physiologic Ceiling
This is another concept that gets lost in discussions about testosterone.
The conventional reference interval generally describes the central 95% of a defined reference population.
That means approximately:
2.5% of healthy individuals may fall below the lower limit
2.5% may fall above the upper limit
by definition.
Therefore, the 97.5th percentile is not:
“The maximum concentration the human body can produce.”
It is:
“The concentration below which approximately 97.5% of this selected reference population fell under these measurement conditions.”
Those are very different statements.
This distinction works in both directions.
A testosterone level of 270 ng/dL can technically fall inside some laboratory reference intervals.
Likewise, a testosterone concentration modestly above the statistical upper reference limit does not automatically prove pathologic androgen excess.
Reference ranges are extraordinarily useful.
But they describe populations.
They do not replace clinical physiology.
But There Is Another Question: Have Men’s Testosterone Levels Declined Across Generations?
Possibly.
And importantly, this is a separate issue from assay harmonization.
Several studies have reported that men measured in more recent eras had lower testosterone concentrations than similarly aged men measured in earlier eras.
One of the best-known examples comes from the Massachusetts Male Aging Study.
Investigators followed population-based samples across three periods spanning approximately 1987 to 2004 and found evidence of a population-level decline in testosterone that could not be explained by chronological aging alone.
This suggested that a 50-year-old man measured in a later calendar period could, on average, have lower testosterone than a 50-year-old man measured years earlier.
A separate analysis from the same cohort also demonstrated that declining health and lifestyle factors—including increases in body weight—could substantially accelerate testosterone decline.
More recently, investigators using NHANES data from more than 4,000 adolescent and young adult men between 1999 and 2016 reported that average testosterone concentrations were lower in later survey cycles. The association persisted even after adjustment for several potential confounders and was seen even among normal-BMI men, although assay differences and residual confounding remain important limitations.
European data have also shown secular changes. Danish population surveys found lower total testosterone in more recently studied men, although much of that difference was attenuated after adjustment for rising BMI, and calculated free testosterone did not show the same independent trend.
So the fairest conclusion is:
There is evidence that testosterone concentrations may have declined across generations, but the magnitude, mechanisms, and degree to which obesity, metabolic health, lifestyle, assay methodology and other factors explain that decline remain uncertain.
Did Men “Used to Run at 1,000–1,200”?
We should be careful here.
The generational data do not establish that average young men decades ago routinely had testosterone levels of 1,000 or 1,200 ng/dL.
That would be an overstatement.
What the evidence suggests is more modest:
Men of the same age may have had somewhat higher average testosterone concentrations in previous generations.
That is interesting—but it should not be confused with the original Framingham 1,197 ng/dL upper percentile.
Framingham Generation 3 was not a group of men measured in the 1950s.
The 2011 paper used a relatively contemporary cohort.
Therefore:
The difference between 1,197 and 916 is primarily an assay-harmonization story.
The possibility that average testosterone has fallen across generations is a separate biological and epidemiologic story.
Both matter.
But they are not the same thing.
And This Raises an Interesting Philosophical Question
What exactly do we mean when we say a testosterone concentration is “normal”?
Usually we mean:
“This result falls within the statistical distribution observed in a selected population.”
That is useful.
But population norms can themselves change.
Modern populations have higher rates of:
obesity
insulin resistance
metabolic disease
sleep disturbance
medication exposure
chronic illness
Many of those factors can influence testosterone physiology.
That does not mean we should arbitrarily use testosterone concentrations from previous generations as therapeutic targets.
But it does mean that:
“Common in today’s population” and “optimal human physiology” are not necessarily identical concepts.
Medicine routinely deals with this problem.
The average blood pressure, body weight or fasting glucose of a population does not necessarily define ideal physiology.
Testosterone deserves the same level of nuance.
So Is a Testosterone of 1,200 Physiologic?
Now we can answer the question more precisely.
Can an untreated healthy man naturally produce a measured testosterone around 1,200 ng/dL?
Yes.
The original Framingham reference population documented exactly that using LC-MS/MS.
Is 1,200 within the modern CDC-harmonized central 95% reference range?
No.
The harmonized 97.5th percentile in healthy nonobese men ages 19–39 was approximately 916 ng/dL.
Does being above 916 mean 1,200 is biologically impossible without drugs?
No.
A percentile is not a physiologic ceiling.
Does the fact that some healthy men naturally reach 1,200 mean TRT patients should routinely be targeted there?
Absolutely not.
That is a completely different question.
Physiologic Does Not Automatically Mean an Appropriate TRT Target
This is where the argument can swing too far in the opposite direction.
Someone could reasonably look at the Framingham data and say:
“If healthy young men naturally reach 1,200 or 1,300, why shouldn’t everyone on TRT?”
Because observing a concentration somewhere in the healthy population does not establish that maintaining every treated man at that concentration improves outcomes.
A naturally high-testosterone man has an intact hypothalamic-pituitary-gonadal axis.
His testosterone production:
varies throughout the day
remains under endogenous feedback control
preserves intratesticular testosterone
preserves gonadotropin signaling
produces a specific individual free-T/SHBG relationship
Exogenous testosterone changes that physiology.
It can suppress spermatogenesis.
It alters intratesticular testosterone.
It can raise hematocrit.
It can affect estradiol, SHBG and blood pressure.
And depending on the formulation and dosing schedule, it may create testosterone exposure patterns that do not resemble natural secretion.
So:
Biologically possible does not automatically mean therapeutically necessary—or therapeutically optimal.
One Testosterone Number Also Tells You Very Little About TRT Exposure
This is especially important with injectable testosterone.
Imagine a man injects testosterone cypionate and has a level of:
1,200 ng/dL
two days later.
Several days afterward, he may be:
850
then:
700
then:
550
before his next dose.
Another patient might maintain testosterone around:
1,100–1,300
through almost the entire dosing interval.
Those are not the same androgen exposures.
Yet both could have a laboratory result labeled:
“Testosterone 1,200.”
This is why injection frequency, dose and laboratory timing matter so much.
A single concentration is a snapshot.
What tissues experience is a concentration-versus-time curve.
And that matters far more than simply asking whether one number is red on the laboratory report.
SHBG Changes the Entire Interpretation
Total testosterone is also only part of the story.
Sex hormone-binding globulin—or SHBG—binds a large portion of circulating testosterone.
A man with higher SHBG may have:
Total testosterone: 1,000 ng/dL
while his free testosterone remains relatively ordinary.
Another man with very low SHBG might have:
Total testosterone: 500 ng/dL
with a comparatively high free testosterone concentration.
Those men may have dramatically different biologically available androgen exposure despite very different-looking total testosterone values.
That is why total testosterone should not always be interpreted in isolation.
SHBG becomes especially relevant in men with:
obesity
insulin resistance
thyroid disease
liver disease
major changes in body composition
certain medications
unusual total testosterone results
discordance between symptoms and total testosterone
The question is not simply:
“What is the total testosterone?”
It is:
“What does this total testosterone mean in this particular man’s physiology?”
Free Testosterone Has Measurement Problems Too
It might seem easier to ignore total testosterone and simply follow free testosterone.
Unfortunately, free testosterone introduces another measurement challenge.
Different laboratories use:
equilibrium dialysis
calculated free testosterone
direct analog assays
different binding equations
different reference intervals
Those methods are not interchangeable.
So once again, the laboratory method matters.
This is why thoughtful hormone medicine requires more than simply reacting to whether a value sits inside or outside a printed reference range.
“1,200” Also Is Not the Same Thing as an Anabolic Steroid Cycle
Another common mistake is to treat any testosterone value above the laboratory range as equivalent to anabolic steroid use.
That is not physiologically accurate.
A brief testosterone peak of 1,100–1,200 ng/dL during replacement therapy is not equivalent to sustained testosterone concentrations of several thousand ng/dL produced by high-dose androgen use.
And neither is necessarily equivalent to stacking multiple anabolic-androgenic steroids.
Androgen exposure depends on:
dose
duration
concentration
free testosterone
pharmacokinetics
additional compounds
tissue exposure
individual susceptibility
There is not a magical point at 917 ng/dL where replacement therapy suddenly becomes a steroid cycle.
But that does not mean escalating testosterone indefinitely is harmless.
Dose still matters.
Exposure still matters.
Safety still matters.
What Should TRT Actually Target?
This is where good medicine should become much less exciting than social-media arguments.
The goal of testosterone therapy should not be:
“Get everyone to 1,200.”
It also should not necessarily be:
“Never allow anyone above 900.”
The goal is to restore appropriate androgen physiology while balancing symptom improvement against unnecessary exposure and risk.
That means considering:
Symptoms and response
libido
sexual function
energy
mood
motivation
recovery
body composition
overall well-being
Testosterone physiology
total testosterone
free testosterone
SHBG
estradiol when clinically appropriate
Pharmacokinetics
formulation
dose
dosing frequency
injection route
timing of laboratory testing
peak-to-trough variability
Safety
hemoglobin
blood pressure
prostate monitoring when appropriate
sleep apnea
The rest of the patient
sleep
nutrition
resistance training
obesity
insulin resistance
thyroid function
medication effects
alcohol
fertility goals
That is very different from treating one laboratory number.
So What Should We Call a Testosterone of 1,200?
I would describe it precisely.
A testosterone of 1,200 ng/dL is above the modern CDC-harmonized central reference interval for healthy young men.
That is factual.
But calling it automatically:
“dangerously supraphysiologic”
requires more information.
I would want to know:
Was the patient taking testosterone?
Which formulation?
What dose?
When was the blood drawn?
Was this a peak, midpoint or trough?
What is the SHBG?
What is the free testosterone?
Is this concentration sustained?
What is the hematocrit?
What is the blood pressure?
Are there adverse effects?
What clinical benefit has occurred?
Is fertility important?
Are other androgenic compounds being used?
Without those answers, 1,200 is just one data point.
What the Framingham Story Actually Teaches Us
The takeaway should not be:
“1,200 is normal.”
And it should not be:
“Anything over 916 is abnormal.”
The real lessons are more interesting.
Healthy male testosterone physiology has a wide distribution.
Some untreated healthy men can naturally measure considerably higher than the population median.
Assay calibration matters.
Even high-quality LC-MS/MS methods can produce systematically different absolute values unless they are standardized to a common reference.
Reference intervals describe populations.
They do not establish absolute biological ceilings.
Populations themselves may change.
Several studies suggest testosterone concentrations have declined across calendar time or birth cohorts, although the magnitude and causes remain debated.
Total testosterone does not equal androgen exposure.
SHBG, free testosterone and pharmacokinetics matter.
Physiologic possibility is not the same as a treatment target.
Finding naturally occurring testosterone values of 1,200 does not establish that every man on TRT should be maintained there.
And finally:
Good TRT medicine requires clinical judgment.
Not reflexively treating a number upward.
Not reflexively treating a number downward.
Understanding the physiology behind it.
The Bigger Lesson: Treat the Man, Not the Number
A laboratory reference range is an extraordinarily valuable tool.
But it cannot tell you everything about an individual patient.
A testosterone level needs context.
So does a free testosterone level.
So does a hematocrit.
And so does a symptom.
The question is not:
“Is 1,200 good or bad?”
The better question is:
“What does 1,200 mean in this particular man, measured by this assay, at this point in his dosing cycle, with this SHBG, this free testosterone, this clinical response and this safety profile?”
That is a much harder question.
It is also much closer to good testosterone medicine.
The Fit & Fine Health Approach
At Fit & Fine Health, testosterone therapy is not managed by chasing a universal number.
Evaluation considers the broader hormonal and metabolic picture—including total testosterone, free testosterone, SHBG, pituitary function when appropriate, hematologic monitoring, prostate health, cardiovascular risk, sleep, body composition, nutrition, training and fertility goals.
Because prescribing testosterone is relatively easy.
Understanding the physiology—and treating the man attached to the laboratory result—is the harder part.
Dr. David Hall, MD, CWC
Board-Certified Urologist
Founder, Fit & Fine Health
References
Bhasin S, et al. Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study.J Clin Endocrinol Metab. 2011.
Travison TG, et al. Harmonized reference ranges for circulating testosterone levels in men of four cohort studies in the United States and Europe.J Clin Endocrinol Metab. 2017.
Travison TG, et al. A population-level decline in serum testosterone levels in American men.J Clin Endocrinol Metab. 2007.
Travison TG, et al. The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. J Clin Endocrinol Metab. 2007.
Lokeshwar SD, et al. Decline in serum testosterone levels among adolescent and young adult men in the USA. Eur Urol Focus. 2021.
Andersson AM, et al. Secular decline in male testosterone and sex hormone binding globulin serum levels in Danish population surveys. J Clin Endocrinol Metab. 2007.
This article is intended for general educational purposes and is not individualized medical advice. Testosterone symptoms can overlap with many other medical conditions. Diagnosis and treatment decisions should be made with a qualified healthcare professional after appropriate evaluation.